David Badawi - 14 Jul 2021 Form 3 Insider Report for Sight Sciences, Inc. (SGHT)

Role
Chief Technology Officer, Director
Signature
/s/ Jeremy Hayden, Attorney-in-Fact for David Badawi
Issuer symbol
SGHT
Transactions as of
14 Jul 2021
Net transactions value
$0
Form type
3
Filing time
14 Jul 2021, 20:49:24 UTC
Next filing
11 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SGHT Common Stock 1,441,196 14 Jul 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding SGHT Stock Option (Right to Buy) 14 Jul 2021 Common Stock 150,000 $0.1100 Direct F1
holding SGHT Stock Option (Right to Buy) 14 Jul 2021 Common Stock 40,000 $0.1200 Direct F1
holding SGHT Stock Option (Right to Buy) 14 Jul 2021 Common Stock 90,000 $0.2300 Direct F1
holding SGHT Stock Option (Right to Buy) 14 Jul 2021 Common Stock 40,000 $0.2300 Direct F1
holding SGHT Stock Option (Right to Buy) 14 Jul 2021 Common Stock 200,000 $10.96 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options are fully vested and exercisable.
F2 The option vests and becomes exercisable in 48 equal monthly installments with the first installment vesting on June 24, 2021.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney